## **Core Concept**
E-cadherin is a transmembrane glycoprotein that plays a crucial role in cell-cell adhesion, particularly in epithelial tissues. It is encoded by the CDH1 gene. Deficiencies or mutations in the E-cadherin gene have been associated with certain types of cancer due to loss of cell adhesion.

## **Why the Correct Answer is Right**
The correct answer, **CDH1**, is the gene that encodes for E-cadherin. A deficiency or mutation in this gene leads to reduced or absent E-cadherin expression, which can result in the loss of cell-cell adhesion. This loss is a key step in the process of epithelial-to-mesenchymal transition (EMT), a phenomenon often observed in cancer progression, particularly in carcinomas. Hereditary diffuse gastric cancer (HDGC) is a well-known condition associated with germline mutations in the CDH1 gene.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While genetic deficiencies can lead to various diseases, option A is not specified. However, if it does not relate to the CDH1 gene, it would be incorrect because CDH1 is the gene directly associated with E-cadherin.
- **Option B:** Similarly, without specifics, if option B does not correspond to CDH1, it would be incorrect for the same reason.
- **Option C:** Again, lacking specifics, if this option does not refer to CDH1, it would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A significant clinical correlation with E-cadherin gene deficiency is Hereditary Diffuse Gastric Cancer (HDGC). Individuals with germline mutations in CDH1 have a significantly increased risk of developing diffuse gastric cancer, and there is also an association with lobular breast cancer. Prophylactic gastrectomy is often considered in these patients due to the high risk of gastric cancer.

## **Correct Answer:** D. CDH1